Concepts (122)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Hemoperfusion | 1 | 2021 | 260 | 0.66 | Why? |
| Out-of-Hospital Cardiac Arrest | 2 | 2019 | 1047 | 0.40 | Why? |
| Cardiopulmonary Resuscitation | 2 | 2019 | 1876 | 0.37 | Why? |
| Adenosine Monophosphate | 1 | 2021 | 5652 | 0.25 | Why? |
| Alanine | 1 | 2021 | 5687 | 0.25 | Why? |
| Emergency Medical Services | 1 | 2019 | 3557 | 0.24 | Why? |
| Germany | 10 | 2021 | 9196 | 0.23 | Why? |
| Meningitis, Pneumococcal | 1 | 2021 | 35 | 0.22 | Why? |
| Immune Reconstitution Inflammatory Syndrome | 1 | 2021 | 66 | 0.21 | Why? |
| Extracorporeal Membrane Oxygenation | 7 | 2021 | 5002 | 0.21 | Why? |
| Furans | 1 | 2021 | 156 | 0.20 | Why? |
| Tuberculosis, Meningeal | 1 | 2021 | 100 | 0.20 | Why? |
| Esophageal Fistula | 1 | 2018 | 11 | 0.19 | Why? |
| Triazines | 1 | 2021 | 246 | 0.19 | Why? |
| Bronchial Fistula | 1 | 2018 | 28 | 0.19 | Why? |
| Isoflurane | 1 | 2018 | 38 | 0.18 | Why? |
| Pyrroles | 1 | 2021 | 292 | 0.18 | Why? |
| Chromatography, Liquid | 1 | 2021 | 640 | 0.17 | Why? |
| Adenosine | 1 | 2021 | 509 | 0.16 | Why? |
| Blood Chemical Analysis | 1 | 2021 | 541 | 0.16 | Why? |
| Albumins | 1 | 2018 | 324 | 0.16 | Why? |
| Hypothermia, Induced | 1 | 2018 | 176 | 0.15 | Why? |
| Propofol | 1 | 2018 | 172 | 0.15 | Why? |
| Proton Pump Inhibitors | 1 | 2020 | 377 | 0.15 | Why? |
| Tandem Mass Spectrometry | 1 | 2021 | 1031 | 0.14 | Why? |
| Fluid Therapy | 1 | 2018 | 628 | 0.13 | Why? |
| Cerebral Hemorrhage | 1 | 2021 | 820 | 0.12 | Why? |
| Hospital Bed Capacity | 1 | 2020 | 1300 | 0.12 | Why? |
| Hypnotics and Sedatives | 1 | 2018 | 624 | 0.12 | Why? |
| Shock, Cardiogenic | 1 | 2018 | 700 | 0.11 | Why? |
| Combined Modality Therapy | 1 | 2021 | 3395 | 0.11 | Why? |
| Resuscitation | 1 | 2017 | 638 | 0.11 | Why? |
| Renal Replacement Therapy | 1 | 2020 | 1530 | 0.11 | Why? |
| Acute Kidney Injury | 2 | 2021 | 5762 | 0.10 | Why? |
| Delirium | 1 | 2020 | 1061 | 0.10 | Why? |
| Coronary Angiography | 1 | 2019 | 2275 | 0.10 | Why? |
| Patient Care Management | 1 | 2020 | 1514 | 0.09 | Why? |
| Hospitals, University | 1 | 2020 | 4173 | 0.09 | Why? |
| Academic Medical Centers | 1 | 2020 | 3088 | 0.08 | Why? |
| Heart Arrest | 1 | 2018 | 1239 | 0.08 | Why? |
| Lopinavir | 1 | 2021 | 4308 | 0.08 | Why? |
| Tuberculosis | 2 | 2021 | 2895 | 0.08 | Why? |
| Inpatients | 1 | 2020 | 5161 | 0.07 | Why? |
| Adrenal Cortex Hormones | 1 | 2021 | 6537 | 0.06 | Why? |
| Spirochaetales Infections | 1 | 2021 | 10 | 0.06 | Why? |
| Intensive Care Units | 4 | 2021 | 29594 | 0.06 | Why? |
| Retrospective Studies | 10 | 2021 | 105322 | 0.06 | Why? |
| Brain Abscess | 1 | 2021 | 50 | 0.05 | Why? |
| Adsorption | 1 | 2021 | 261 | 0.05 | Why? |
| Pipecolic Acids | 1 | 2020 | 84 | 0.05 | Why? |
| Citric Acid | 1 | 2020 | 116 | 0.05 | Why? |
| Coinfection | 1 | 2020 | 6820 | 0.05 | Why? |
| Registries | 4 | 2021 | 12327 | 0.05 | Why? |
| Somalia | 1 | 2018 | 62 | 0.05 | Why? |
| Anticoagulants | 1 | 2020 | 9563 | 0.05 | Why? |
| Equipment Failure | 1 | 2020 | 197 | 0.05 | Why? |
| Influenza, Human | 2 | 2020 | 10779 | 0.05 | Why? |
| Cytokines | 1 | 2021 | 15010 | 0.05 | Why? |
| Mediastinitis | 1 | 2018 | 37 | 0.05 | Why? |
| Humans | 19 | 2021 | 930598 | 0.04 | Why? |
| Arginine | 1 | 2020 | 377 | 0.04 | Why? |
| Aged | 11 | 2021 | 215776 | 0.04 | Why? |
| Chemotherapy, Adjuvant | 1 | 2021 | 606 | 0.04 | Why? |
| Hydroxychloroquine | 1 | 2021 | 12447 | 0.04 | Why? |
| Chi-Square Distribution | 1 | 2020 | 961 | 0.04 | Why? |
| Hospital Mortality | 1 | 2020 | 22087 | 0.04 | Why? |
| Tertiary Healthcare | 1 | 2020 | 616 | 0.04 | Why? |
| Survival Rate | 2 | 2021 | 9206 | 0.04 | Why? |
| Coma | 1 | 2018 | 204 | 0.04 | Why? |
| Middle Aged | 10 | 2021 | 270681 | 0.04 | Why? |
| HIV Infections | 1 | 2021 | 11620 | 0.04 | Why? |
| Male | 12 | 2021 | 367725 | 0.04 | Why? |
| Creatinine | 1 | 2021 | 1443 | 0.03 | Why? |
| Survival Analysis | 2 | 2018 | 7592 | 0.03 | Why? |
| Time Factors | 1 | 2017 | 31397 | 0.03 | Why? |
| Treatment Outcome | 2 | 2018 | 51732 | 0.03 | Why? |
| Female | 11 | 2021 | 380317 | 0.03 | Why? |
| Models, Statistical | 2 | 2020 | 5312 | 0.03 | Why? |
| Propensity Score | 1 | 2021 | 2690 | 0.03 | Why? |
| Adult | 8 | 2021 | 244371 | 0.03 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.03 | Why? |
| Sulfonamides | 1 | 2020 | 1294 | 0.03 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.03 | Why? |
| Heparin, Low-Molecular-Weight | 1 | 2020 | 1731 | 0.03 | Why? |
| Shock, Septic | 1 | 2021 | 1313 | 0.03 | Why? |
| Fatigue | 1 | 2021 | 2479 | 0.03 | Why? |
| Taste Disorders | 1 | 2021 | 1720 | 0.02 | Why? |
| Sleep Initiation and Maintenance Disorders | 1 | 2021 | 1692 | 0.02 | Why? |
| Refugees | 1 | 2018 | 809 | 0.02 | Why? |
| Incidence | 2 | 2021 | 25622 | 0.02 | Why? |
| Antiviral Agents | 1 | 2021 | 41703 | 0.02 | Why? |
| Dyspnea | 1 | 2021 | 3847 | 0.02 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.02 | Why? |
| Heparin | 1 | 2020 | 2600 | 0.02 | Why? |
| Blood Coagulation | 1 | 2020 | 2768 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2021 | 7268 | 0.02 | Why? |
| Critical Care | 2 | 2021 | 14081 | 0.02 | Why? |
| Health Resources | 1 | 2020 | 2592 | 0.02 | Why? |
| Global Health | 2 | 2020 | 13911 | 0.02 | Why? |
| Aged, 80 and over | 3 | 2021 | 88759 | 0.02 | Why? |
| Forecasting | 1 | 2020 | 4492 | 0.02 | Why? |
| Respiration, Artificial | 2 | 2021 | 22116 | 0.02 | Why? |
| Patient Safety | 1 | 2020 | 4885 | 0.02 | Why? |
| ROC Curve | 1 | 2017 | 6024 | 0.02 | Why? |
| Sepsis | 1 | 2021 | 3517 | 0.02 | Why? |
| Length of Stay | 1 | 2021 | 11042 | 0.02 | Why? |
| Tertiary Care Centers | 1 | 2020 | 8248 | 0.02 | Why? |
| Follow-Up Studies | 1 | 2021 | 17020 | 0.02 | Why? |
| Pandemics | 5 | 2020 | 389249 | 0.01 | Why? |
| Logistic Models | 1 | 2017 | 9089 | 0.01 | Why? |
| Risk Factors | 2 | 2021 | 71621 | 0.01 | Why? |
| Quality of Life | 1 | 2021 | 9820 | 0.01 | Why? |
| Hospitals | 1 | 2020 | 11793 | 0.01 | Why? |
| Young Adult | 2 | 2021 | 93724 | 0.01 | Why? |
| Pneumonia | 1 | 2018 | 5652 | 0.01 | Why? |
| Cross Infection | 1 | 2020 | 8675 | 0.01 | Why? |
| Critical Illness | 1 | 2020 | 17281 | 0.01 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2021 | 43792 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.01 | Why? |
| Prospective Studies | 1 | 2017 | 43301 | 0.01 | Why? |
| Antibodies, Viral | 1 | 2021 | 51949 | 0.01 | Why? |
Biever's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(122)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(87)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_